Diversified Healthcare Trust

As of October 3, 2025, Diversified Healthcare Trust shows a mildly bullish trend with mixed signals from indicators, outperforming the S&P 500 recently but lagging over the past year.

As of October 3, 2025, Diversified Healthcare Trust shows a mildly bullish trend with bullish MACD and moving averages, but caution is advised due to a mildly bearish KST, despite a strong year-to-date performance of 90.43% compared to the S&P 500's 14.18%.

As of October 3, 2025, Diversified Healthcare Trust shows a mildly bullish trend, supported by bullish moving averages and MACD, despite mixed signals from other indicators, with a recent month return of 17.11% compared to the S&P 500's 4.15%.

As of September 4, 2025, Diversified Healthcare Trust shows a bullish technical trend with strong MACD and Bollinger Bands indicators, despite mixed signals from KST and OBV, and has significantly outperformed the S&P 500 year-to-date and over three years.

As of March 1, 2023, Diversified Healthcare Trust's valuation has shifted from attractive to risky due to overvaluation and poor performance metrics, including a Price to Book Value of 0.42 and an EV to EBITDA of 2.14, despite a year-to-date stock return of 95.22% that outperformed the S&P 500.

As of March 1, 2023, Diversified Healthcare Trust's valuation has shifted from very attractive to risky due to being overvalued with a negative P/E ratio and unsustainable dividend yield, despite strong recent stock performance.

As of June 18, 2025, Diversified Healthcare Trust shows a strong bullish trend, supported by positive MACD readings, bullish moving averages, and a significant 60% year-to-date return compared to the S&P 500's 2.44%.

As of March 2022, the management team of Diversified Healthcare Trust includes Ms. Lisa Jones (Lead Independent Trustee), Daniel LePage, Mr. Jeffrey Somers, Ms. Jennifer Clark (Managing Trustee), and Mr. John Harrington, all of whom oversee the company's operations and strategy.

Diversified Healthcare Trust is a healthcare REIT focused on healthcare and life sciences, with a market cap of approximately $870.92 million. As of March 2025, it reported net sales of $387 million and a net loss of $9 million, with a dividend yield of 110.13%.

As of Jun 18, Diversified Healthcare Trust has a market capitalization of 870.92 million and reported net sales of 1,511.51 million with a net profit of -292.99 million over the latest four quarters.